التفاصيل البيبلوغرافية
العنوان: |
Real-world experience with CLAIRYG® 50 mg/mL (intravenous immunoglobulin) in children under 12 years with primary immunodeficiency or immmune thrombocytopenia: a post-approval safety study |
المؤلفون: |
Nizar Mahlaoui, Fanny Fouyssac, Françoise Mazingue, Coralie Mallebranche, Malika Barthez-Toullec, Lamia Denti, Kalaivani Ruhier, Marie-Hélène André-Bonnet, Aude Marie-Cardine, Nathalie Aladjidi, Jean-Louis Stephan |
المصدر: |
Frontiers in Pediatrics, Vol 11 (2023) |
بيانات النشر: |
Frontiers Media S.A., 2023. |
سنة النشر: |
2023 |
المجموعة: |
LCC:Pediatrics |
مصطلحات موضوعية: |
immunoglobulin, primary immunodeficiency, Clairyg®, post-approval safety study, real-world experience, pediatrics, Pediatrics, RJ1-570 |
الوصف: |
IntroductionThis study presents the results of a real-life, multicenter, prospective, post-approval safety evaluation of Clairyg® 50 mg/mL, a 5% intravenous immunoglobulin (IVIg) liquid, in 59 children (aged |
نوع الوثيقة: |
article |
وصف الملف: |
electronic resource |
اللغة: |
English |
تدمد: |
2296-2360 |
Relation: |
https://www.frontiersin.org/articles/10.3389/fped.2023.1260296/full; https://doaj.org/toc/2296-2360 |
DOI: |
10.3389/fped.2023.1260296 |
URL الوصول: |
https://doaj.org/article/d8132084468e477497328dbe00d6d619 |
رقم الانضمام: |
edsdoj.8132084468e477497328dbe00d6d619 |
قاعدة البيانات: |
Directory of Open Access Journals |